CyanoCapture

CyanoCapture is a private UK synthetic biology and biomanufacturing company developing engineered cyanobacteria as a platform for both low-cost production of high-value biological products and oral delivery of protein and peptide therapeutics. The company originated with a focus on biological carbon capture, then expanded its platform toward healthcare applications including cyanobacteria-based oral biologics and peptide manufacturing. Its technology combines fast-growing photosynthetic chassis strains, proprietary genetic engineering tools, CRISPR methods, and carboxysome-based protein nanocages for targeted drug delivery. CyanoCapture also works on industrial enzymes, growth factors, interferons, cytokines, serum-free media ingredients, and related biologics. The company remains private and appears to be at a preclinical/platform stage rather than in human clinical development.